MedPath

Comparison of two methods of treatment of sertraline in the treatment of premature ejaculatio

Phase 2
Conditions
Patients with premature ejaculation.
Premature ejaculation
Registration Number
IRCT2013101415006N1
Lead Sponsor
niversity of Medical Sciences Iranian Army
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
50
Inclusion Criteria

male patients; having sex at least once a week; no disease in the form of inclusion.
Exclusion criteria: if the drug has side effects; lack of satisfaction to continue testing; couples apart during testing.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Premature Ejaculation. Timepoint: Before and after intervention. Method of measurement: Assessment of satisfaction spouses before and after intervention.
Secondary Outcome Measures
NameTimeMethod
Headache. Timepoint: During intervention. Method of measurement: Qualitatively, and through the person's statements.;Dizziness. Timepoint: During intervention. Method of measurement: Qualitatively, and through the person's statements.;Vomiting. Timepoint: During intervention. Method of measurement: Qualitatively, and through the person's statements. and after intervention.
© Copyright 2025. All Rights Reserved by MedPath